Welcome to the genitourinary (GU) cancer channel. Explore the latest updates in GU cancer, including expert interviews from major international congresses and news by subtype.

Genitourinary cancer is any cancer of the genitourinary system, including the bladder, prostate, kidneys, testicles, penis, ureter and adrenal glands. The treatment of these cancers are managed by urologists and/or oncologists, depending upon the type of treatment. Minimally-invasive techniques, as well as traditional chemoradiotherapy are utilized.

Exciting advances are being made in the field of genitourinary cancer, including checkpoint inhibitor treatments, new non-steroidal anti-androgens, chemoimmunotherapy combinations and predictive biomarkers.

Genitourinary Cancer

The Genitourinary Cancer Channel on VJOncology is supported by a grant from Pfizer Inc and Merck KGaA.

The supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Genitourinary Cancer Channel, please contact us

Genitourinary Cancer

Welcome to the genitourinary (GU) cancer channel. Explore the latest updates in GU cancer, including expert interviews from major international congresses and news by subtype.

Genitourinary cancer is any cancer of the genitourinary system, including the bladder, prostate, kidneys, testicles, penis, ureter and adrenal glands. The treatment of these cancers are managed by urologists and/or oncologists, depending upon the type of treatment. Minimally-invasive techniques, as well as traditional chemoradiotherapy are utilized.

Exciting advances are being made in the field of genitourinary cancer, including checkpoint inhibitor treatments, new non-steroidal anti-androgens, chemoimmunotherapy combinations and predictive biomarkers.

View all videos
The Genitourinary Cancer Channel on VJOncology is supported by a grant from Pfizer Inc and Merck KGaA.

The supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Genitourinary Cancer Channel, please contact us

Latest videos OncoAlert Colloquium Subtypes Topics Conferences Features Editorial Board

Latest Videos

View all videos
6:14
ESMO highlights: 705MO study in GU cancer
Pavlos Msaouel • 19 Sep 2020
0:53
Immunotherapy in prostate cancer
Emmanuel Seront • 7 Oct 2020
1:35
Unmet needs in mHSPC
Ursula Vogl • 7 Oct 2020
1:29
Genomic testing in prostate cancer
Emmanuel Seront • 7 Oct 2020

GU Cancer Videos by Subtype

Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Penile Cancer
0:53
Immunotherapy in prostate cancer
Emmanuel Seront • 7 Oct 2020
1:35
Unmet needs in mHSPC
Ursula Vogl • 7 Oct 2020
1:29
Genomic testing in prostate cancer
Emmanuel Seront • 7 Oct 2020
0:38
Second-line treatment of mHSPC
Ursula Vogl • 7 Oct 2020
View All Videos
6:14
ESMO highlights: 705MO study in GU cancer
Pavlos Msaouel • 19 Sep 2020
2:04
Unmet need in bladder cancer
Arlene Siefker-Radtke • 14 Oct 2020
4:34
Optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
Arlene Siefker-Radtke • 14 Oct 2020
4:01
NMIBC: relevance of prognostic markers
Amir Mostafid • 9 Oct 2020
View All Videos
9:48
BIONIKK trial update
Yann-Alexandre Vano • 15 Sep 2020
1:43
RCC data at ESMO 2020
Laurence Albiges • 18 Sep 2020
1:03
Treating patients with RCC in 2020 and beyond
Laurence Albiges • 18 Sep 2020
5:26
Updates in 1L urothelial cancer from ESMO 2020
Thomas Powles • 18 Sep 2020
View All Videos
2:54
Risk stratification in metastatic seminoma
Peter Albers • 13 Feb 2020
1:24
Testicular cancer: reducing chemo and radio
Clint Cary • 14 Feb 2020
1:18
Presentation & management benign vs malignant testicular cancer
Clint Cary • 14 Feb 2020
2:04
SEMITEP: reducing testicular cancer chemo
Yohann Loriot • 13 Feb 2020
View All Videos
Penile cancer: avelumab
Srikala Sridhar • 13 Feb 2020
3:07
Vinflunine shows a chemotherapeutic advantage for locally-advanced and metastatic penile cancer
Lisa Pickering • 8 Feb 2018
2:38
The current treatment landscape for penile cancer
Lisa Pickering • 8 Feb 2018
View All Videos

Topics

Trial Updates
Treatment
Immuno-Oncology
Diagnosis
Imaging
6:14
ESMO highlights: 705MO study in GU cancer
Pavlos Msaouel • 19 Sep 2020
3:11
PRS-343 in HER2-Positive Solid Tumors: A trial update
Geoffrey Ku • 24 Sep 2020
3:53
Sacituzumab govitecan in metastatic urothelial carcinoma: updates on the Phase II study
Yohann Loriot • 23 Sep 2020
3:20
Updates on the DANUBE, KEYNOTE-361 and JAVELIN Studies
Yohann Loriot • 23 Sep 2020
View All Videos
6:14
ESMO highlights: 705MO study in GU cancer
Pavlos Msaouel • 19 Sep 2020
0:53
Immunotherapy in prostate cancer
Emmanuel Seront • 7 Oct 2020
1:35
Unmet needs in mHSPC
Ursula Vogl • 7 Oct 2020
1:29
Genomic testing in prostate cancer
Emmanuel Seront • 7 Oct 2020
View All Videos
6:14
ESMO highlights: 705MO study in GU cancer
Pavlos Msaouel • 19 Sep 2020
0:53
Immunotherapy in prostate cancer
Emmanuel Seront • 7 Oct 2020
2:04
Unmet need in bladder cancer
Arlene Siefker-Radtke • 14 Oct 2020
4:34
Optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
Arlene Siefker-Radtke • 14 Oct 2020
View All Videos
5:08
Update on biomarkers in urothelial cancer presented at ESMO 2020
Thomas Powles • 18 Sep 2020
3:40
ProPSMA: PSMA-PET/CT imaging for high risk prostate cancer
Michael Hofman • 18 Jul 2020
3:41
Cell-free DNA for multi-cancer detection
Geoffrey Oxnard • 9 Apr 2020
1:34
Clinicopathologic models in prostate cancer: impact of a 22-gene genomic classifier
Eric Klein • 3 Apr 2020
View All Videos
1:25
Improving precision of high-quality prostate cancer MRI
Anwar Padhani • 14 Oct 2020
5:52
Future of imaging and theranostics in prostate cancer
Jeremie Calais • 9 Oct 2020
4:15
PSMA-PET for patients with high-risk for de novo N1 disease
Jeremie Calais • 9 Oct 2020
1:22
Highlights from EAU 2020
Peter Albers
View All Videos

Conferences

PROSCA/BLADDR 2020
ESMO 2020
ASCO 2020
GU Cancers 2020
0:53
Immunotherapy in prostate cancer
Emmanuel Seront • 7 Oct 2020
1:29
Genomic testing in prostate cancer
Emmanuel Seront • 7 Oct 2020
0:38
Second-line treatment of mHSPC
Ursula Vogl • 7 Oct 2020
1:35
Unmet needs in mHSPC
Ursula Vogl • 7 Oct 2020
View All Videos
6:14
ESMO highlights: 705MO study in GU cancer
Pavlos Msaouel • 19 Sep 2020
3:11
PRS-343 in HER2-Positive Solid Tumors: A trial update
Geoffrey Ku • 24 Sep 2020
3:53
Sacituzumab govitecan in metastatic urothelial carcinoma: updates on the Phase II study
Yohann Loriot • 23 Sep 2020
3:20
Updates on the DANUBE, KEYNOTE-361 and JAVELIN Studies
Yohann Loriot • 23 Sep 2020
View All Videos
2:31
Axitinib plus pembrolizumab in advanced RCC
Michael Atkins • 26 May 2020
1:15
Q-TWiST of lenvatinib + everolimus in advanced RCC
Chung Han-Lee • 29 May 2020
2:38
Safety outcomes of darolutamide vs apalutamide and enzalutamide in nmCRPC
Neal Shore • 21 May 2020
2:29
COVID-19 and cancer care
Neal Shore • 21 May 2020
View All Videos
2:54
Risk stratification in metastatic seminoma
Peter Albers • 13 Feb 2020
7:53
Growing treatment landscape for advanced bladder cancer
Cora Sternberg • 13 Feb 2020
4:31
Current obstacles in the treatment of urothelial carcinoma
Sima Porten • 13 Feb 2020
1:21
Tracy Rose: RCC highlights
Tracy Rose • 13 Feb 2020
View All Videos

Editorial Board

Thomas Powles
MBBS, MRCP, MD
Barts Cancer Institute and The London School of Medicine and Dentistry, UK
Neal Shore
MD, FACS
Carolina Urologic Research Center, South Carolina, SC
Arlene Siefker-Radtke
MD
University of Texas, MD Anderson Cancer Center, Houston, TX
Karim Fizazi
MD, PhD
Institute Gustave Roussy, France
Elizabeth Plimack
MD, MS
Fox Chase Cancer Center, Philadelphia, PA
Sumanta Pal
MD
City of Hope, CA

The GU Channel on VJOncology is supported by a grant from Pfizer Inc and Merck KGaA. The supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Genitourinary (GU) Cancer Channel, please contact us

VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals